Headlands Technologies’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,537
Closed -$430K 973
2025
Q4
$430K Buy
3,537
+556
+19% +$69.8K 0.04% 439
2025
Q3
$334K Buy
+2,981
New +$349K 0.03% 440
2025
Q2
Sell
-8,357
Closed -$562K 1528
2025
Q1
$562K Sell
8,357
-2,903
-26% -$200K 0.06% 269
2024
Q4
$702K Sell
11,260
-809
-7% -$75.3K 0.07% 281
2024
Q3
$1.89M Buy
+12,069
New +$1.86M 0.22% 103
2024
Q2
Sell
-445
Closed -$32.9K 1600
2024
Q1
$32.9K Sell
445
-1,846
-81% -$152K 0.01% 803
2023
Q4
$181K Sell
2,291
-991
-30% -$59.8K 0.05% 290
2023
Q3
$180K Buy
+3,282
New +$236K 0.09% 219

Other funds holding TMDX

Headlands Technologies's TMDX Position: Q1 2026 in Review

Headlands Technologies sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 3,537 shares — an estimated $430K sold.

Headlands Technologies first reported a position in TMDX in Q3 2023 and held it in 8 quarters. The position peaked at $1.89M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Headlands Technologies reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Headlands Technologies sold 3,537 Transmedics shares in Q1 2026, an estimated $430K.
  • Headlands Technologies first reported a position in Transmedics in Q3 2023 and held it in 8 quarters.
  • Headlands Technologies's Transmedics position peaked at $1.89M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.